NCT01954628 - Efficacy and Safety of AQX-1125 in Unstable COPD | Biotech Hunter

Enrollment

400

Participants

Timeline

Start Date

October 31, 2013

Primary Completion Date

July 31, 2015

Study Completion Date

December 31, 2015

Conditions

COPD

Interventions

DRUG

AQX-1125

Synthetic SHIP1 activator

DRUG

Placebo

Placebo control

Trial Locations (8)

Department of Respiratory & Sleep Medicine, Westmead Hospital, Wentworthville

University of Cincinnati, Cincinnati

Department of Respiratory Medicine, Odense University Hospital, Odense

Biomedicum Helsinki, Helsinki

Csongrád Megyei Melkasi Betegségek Szakkórháza, Deszk

P3 Research, Wellington

Medical University of Lodz, Lodz

Lung and Allergy Clinic, Skåne University Hospital, Lund